BR9909350A - Compostos, composição, utilização de um composto, e, processos para preparação dos compostos, para transferência de ácido nucleicos para as células e para tratamento de doenças por meio de administração de um ácido nucleico - Google Patents
Compostos, composição, utilização de um composto, e, processos para preparação dos compostos, para transferência de ácido nucleicos para as células e para tratamento de doenças por meio de administração de um ácido nucleicoInfo
- Publication number
- BR9909350A BR9909350A BR9909350-2A BR9909350A BR9909350A BR 9909350 A BR9909350 A BR 9909350A BR 9909350 A BR9909350 A BR 9909350A BR 9909350 A BR9909350 A BR 9909350A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- nucleic acids
- cells
- processes
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/12—Nitrogen atoms not forming part of a nitro radical
- C07D239/14—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
"COMPOSTOS, COMPOSIçãO, UTILIZAçãO DE UM COMPOSTO, E, PROCESSOS PARA PREPARAçãO DOS COMPOSTOS, PARA TRANSFERêNCIA DE áCIDOS NUCLEICOS PARA AS CéLULAS E PARA TRATAMENTO DE DOENçAS POR MEIO DE ADMINISTRAçãO DE UM áCIDO NUCLEICO". A presente invenção refere-se a novos compostos úteis como agentes de transferência de ácidos nucleicos nas células. Estes novos compostos são relacionados, mais particularmente, com a família das lipopoliaminas, e comportam pelo menos uma função amidina cíclica. Eles são úteis para a transfecção dos ácidos nucleicos de interesse em diferentes tipos celulares, tanto in vitro como in vivo ou ex vivo.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9804121A FR2777017B1 (fr) | 1998-04-02 | 1998-04-02 | Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs applications |
US8584598P | 1998-05-18 | 1998-05-18 | |
PCT/FR1999/000740 WO1999051581A1 (fr) | 1998-04-02 | 1999-03-30 | Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs applications |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9909350A true BR9909350A (pt) | 2000-12-12 |
Family
ID=26234240
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9909350-2A BR9909350A (pt) | 1998-04-02 | 1999-03-30 | Compostos, composição, utilização de um composto, e, processos para preparação dos compostos, para transferência de ácido nucleicos para as células e para tratamento de doenças por meio de administração de um ácido nucleico |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1068188A1 (pt) |
JP (1) | JP2002513543A (pt) |
KR (1) | KR20010042318A (pt) |
CN (1) | CN1294582A (pt) |
AU (1) | AU759301B2 (pt) |
BR (1) | BR9909350A (pt) |
CA (1) | CA2324931A1 (pt) |
HU (1) | HUP0102455A3 (pt) |
IL (1) | IL138625A0 (pt) |
NO (1) | NO317225B1 (pt) |
PL (1) | PL342886A1 (pt) |
WO (1) | WO1999051581A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020091242A1 (en) | 2000-10-11 | 2002-07-11 | Michel Bessodes | Acid-sensitive compounds, their preparation and uses |
ITMI20050222A1 (it) | 2005-02-15 | 2006-08-16 | Milano Politecnico | Lipidi cationici per la trasfezione di acidi nucleici |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2645866B1 (fr) * | 1989-04-17 | 1991-07-05 | Centre Nat Rech Scient | Nouvelles lipopolyamines, leur preparation et leur emploi |
US5283185A (en) * | 1991-08-28 | 1994-02-01 | University Of Tennessee Research Corporation | Method for delivering nucleic acids into cells |
FR2714830B1 (fr) * | 1994-01-10 | 1996-03-22 | Rhone Poulenc Rorer Sa | Composition contenant des acides nucléiques, préparation et utilisations. |
FR2727679B1 (fr) * | 1994-12-05 | 1997-01-03 | Rhone Poulenc Rorer Sa | Nouveaux agents de transfection et leurs applications pharmaceutiques |
FR2741066B1 (fr) * | 1995-11-14 | 1997-12-12 | Rhone Poulenc Rorer Sa | Nouveaux agents de transfection et leurs applications pharmaceutiques |
DE69703878T2 (de) * | 1996-03-01 | 2001-04-26 | Centre National De La Recherche Scientifique (C.N.R.S.), Paris | Guanidinium-verbindungen, pharmazeutische präparate davon und ihre verwendungen |
-
1999
- 1999-03-30 CA CA002324931A patent/CA2324931A1/fr not_active Abandoned
- 1999-03-30 HU HU0102455A patent/HUP0102455A3/hu unknown
- 1999-03-30 IL IL13862599A patent/IL138625A0/xx unknown
- 1999-03-30 KR KR1020007010867A patent/KR20010042318A/ko not_active Application Discontinuation
- 1999-03-30 PL PL99342886A patent/PL342886A1/xx not_active Application Discontinuation
- 1999-03-30 BR BR9909350-2A patent/BR9909350A/pt not_active IP Right Cessation
- 1999-03-30 CN CN99804274A patent/CN1294582A/zh active Pending
- 1999-03-30 WO PCT/FR1999/000740 patent/WO1999051581A1/fr not_active Application Discontinuation
- 1999-03-30 EP EP99910463A patent/EP1068188A1/fr not_active Withdrawn
- 1999-03-30 JP JP2000542302A patent/JP2002513543A/ja not_active Withdrawn
-
2000
- 2000-05-12 AU AU34061/00A patent/AU759301B2/en not_active Ceased
- 2000-09-25 NO NO20004780A patent/NO317225B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
IL138625A0 (en) | 2001-10-31 |
NO317225B1 (no) | 2004-09-20 |
PL342886A1 (en) | 2001-07-16 |
HUP0102455A2 (hu) | 2001-10-28 |
KR20010042318A (ko) | 2001-05-25 |
EP1068188A1 (fr) | 2001-01-17 |
AU3406100A (en) | 2000-11-30 |
CN1294582A (zh) | 2001-05-09 |
HUP0102455A3 (en) | 2003-09-29 |
AU759301B2 (en) | 2003-04-10 |
JP2002513543A (ja) | 2002-05-14 |
WO1999051581A1 (fr) | 1999-10-14 |
NO20004780D0 (no) | 2000-09-25 |
NO20004780L (no) | 2000-11-01 |
CA2324931A1 (fr) | 1999-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9801207A2 (hu) | Nukleinsavat tartalmazó készítmények, előállításuk és alkalmazásuk | |
Polak et al. | Mode of action of the 2-nitroimidazole derivative benznidazole | |
Martini | Marburg virus disease | |
FI962799A0 (fi) | Nukleiinihappoja sisältävä valmiste, sen valmistus ja käyttö | |
BR0008590A (pt) | Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto | |
EA201070030A1 (ru) | Синтез и применение антиинвертированных фосфоротиоатных аналогов кэп-структуры матричной phk | |
ES2156421T3 (es) | Composiciones utiles para la transferencia de polinucleotidos terapeuticamente activos a una celula diana y su utilizacion en la terapia genica. | |
MX9706380A (es) | Guanidinas de acidos alquenil-carboxilicos sustituidos con fenilo, procedimientos para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como un medicamento que las contiene. | |
DE69713526D1 (de) | Lösliche prodrugs von paclitaxel | |
BRPI0515684A (pt) | formulações de cristais injetáveis ativas de longa duração de metabólitos de estradiol, e métodos de utilização das mesmas | |
BR0010716A (pt) | Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas | |
BR0214757A (pt) | Formulações farmacêuticas de derivados de platina | |
BR0109266A (pt) | Composto, composição farmacêutica, método de tratamento de um mamìfero afetado com um câncer, método de liberação de um composto nas células de um mamìfero afetado com um câncer e uso do composto | |
BR0007360A (pt) | Composição de liberação controlada | |
DE69828045D1 (de) | Verbindungen, ihre herstellung und ihre verwendung für den transfer von nucleinsäuren in zellen | |
ATE16191T1 (de) | Stabile salze von s-adenosinylmethionin, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen welche als aktive substanz diese derivate enthalten. | |
TR200103153T2 (tr) | Yeni bileşimler | |
EP0271795A3 (de) | Octahydro-10-oxo-6H-pyridazo [1,2-a] [1,2] diazepin-Derivate, Zwischenprodukte und Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel | |
BR0016133A (pt) | Composto, formulação farmacêutica, e, uso de um composto | |
GR1002847B (el) | Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως | |
AR008387A1 (es) | Nuevas 5-fenoxialquil-tiazolidin-2,4-dionas, procedimientos para obtenerlas, nuevos compuestos intermedios de estos procedimientos ycomposiciones farmaceuticas que contienen las nuevas 5-fenoxialquil-tiazolidin- 2,4-dionas | |
MY114944A (en) | Propanolamine derivatives, processes for their preparation pharmaceuticals comprising these compounds, and their use | |
BR9812553A (pt) | Formulação medicamentosa com liberação de substância ativa controlada | |
ATE220912T1 (de) | Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung | |
BR9909350A (pt) | Compostos, composição, utilização de um composto, e, processos para preparação dos compostos, para transferência de ácido nucleicos para as células e para tratamento de doenças por meio de administração de um ácido nucleico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A,8A E 9A ANUIDADES |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1945 DE 15 - 04 - 2008. |